|
NSMCE4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.918600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.315400E-01 |
| Normal-vs-Stage2 |
1.683830E-01 |
| Normal-vs-Stage3 |
7.062200E-02 |
| Normal-vs-Stage4 |
9.977200E-01 |
| Stage1-vs-Stage2 |
3.243200E-01 |
| Stage1-vs-Stage3 |
1.134180E-02 |
| Stage1-vs-Stage4 |
5.736000E-01 |
| Stage2-vs-Stage3 |
1.697860E-02 |
| Stage2-vs-Stage4 |
2.214200E-01 |
| Stage3-vs-Stage4 |
1.656370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.327000E-01 |
| Normal-vs-AfricanAmerican |
5.769800E-02 |
| Normal-vs-Asian |
5.729000E-01 |
| Caucasian-vs-AfricanAmerican |
2.425500E-02 |
| Caucasian-vs-Asian |
6.909200E-01 |
| AfricanAmerican-vs-Asian |
6.484400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.734000E-01 |
| Normal-vs-Female |
3.924300E-02 |
| Male-vs-Female |
2.196300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.543000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.107400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.509200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.180200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.623000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.185200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.597800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.139600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.741800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.559500E-04 |
| Normal-vs-Grade 2 |
2.924300E-02 |
| Normal-vs-Grade 3 |
1.462840E-01 |
| Normal-vs-Grade 4 |
9.546200E-02 |
| Grade 1-vs-Grade 2 |
9.929800E-02 |
| Grade 1-vs-Grade 3 |
1.937960E-03 |
| Grade 1-vs-Grade 4 |
3.358700E-03 |
| Grade 2-vs-Grade 3 |
2.610500E-04 |
| Grade 2-vs-Grade 4 |
1.221580E-03 |
| Grade 3-vs-Grade 4 |
4.505200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.857200E-03 |
| Normal-vs-ccB subtype |
2.544900E-03 |
| ccA subtype-vs-ccB subtype |
2.56209999882628E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.532200E-01 |
| Normal-vs-N1 |
5.158100E-02 |
| N0-vs-N1 |
1.065580E-01 |
|
|
